EYEG

Q: What is the price of EyeGate Pharmaceuticals (EYEG) today?

The price of EyeGate Pharmaceuticals (EYEG) today is R$ 195,95, with a variation of 4.37% compared to the last year. The price of EyeGate Pharmaceuticals (EYEG) started the year trading around R$ 188,60 and today it is at R$ 195,95. Follow the real-time price chart, the historical price of EyeGate Pharmaceuticals (EYEG), and stock data from Ibovespa and international markets.

Q: When does EyeGate Pharmaceuticals (EYEG) pay dividends?

EyeGate Pharmaceuticals (EYEG) distributed dividends in the last year,in the months of January, February, March, April, May, June, July, August, September, October, November e December totaling R$ 9,41. The Dividend Yield for the last 12 months is 0,25%.

Q: EyeGate Pharmaceuticals (EYEG) is it worth it?

Currently, EyeGate Pharmaceuticals (EYEG) is priced at R$ 195,95, with a P/E of -24,37%, representing a deviation of -1,12% from its historical average P/E. In the last year, the stock showed a variation of 4.37% in its price and distributed R$ 9,41 in dividends, resulting in a Dividend Yield of 0,25%. The total shareholder return was 4,37%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of EyeGate Pharmaceuticals (EYEG)?

Investing in stocks of EyeGate Pharmaceuticals (EYEG) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of EyeGate Pharmaceuticals (EYEG) yield today?

The yield of EyeGate Pharmaceuticals (EYEG) was 2,38% in the last month, 4,37% in the last year and 941,29% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of R$ 11,23 in dividends, um Dividend Yield de 0,25%.If you wanted to buy 100 stocks of EyeGate Pharmaceuticals (EYEG) today, the total investment would be R$ 19.595,35, based on the current price of R$ 195,95.If past performance were to repeat, the return on your investment would be:In 1 year: R$ 20.451,66In 5 years: R$ 204.044,37In 10 years: 13.393,42It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

EyeGate Pharmaceuticals Inc.

Price

US$ 36,36

variation (12m)

4,37%

p/l

-24,37

p/vp

14,66

DIVIDEND YIELD

0,25%

price EYEG

BVMF

EYEG

If you had invested

years ago

6 months

1 year

5 years

10 years

today you would have

today you would have:

*The figure considers the reinvestment of dividends.

profitability of EYEG

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

2,38%

3 months

4,82%

1 year

4,37%

2 years

0,00%

5 years

941,29%

10 years

-31,65%

real profitability

profitability minus inflation.

1 month

2,38%

3 months

4,66%

1 year

-0,29%

2 years

0,00%

5 years

666,58%

10 years

-59,22%

Indicators EYEG

check out the fundamentals of EyeGate Pharmaceuticals shares

P/E

-24,37

Sector: -0,86 Industry: 18,80

P/SALES RATIO (PSR)

10.541,91

Sector: 1,91 Industry: 2,95

P/BV

14,66

Sector: 2,18 Industry: 3,24

DIVIDEND YIELD (DY)

0,25%

Sector: - Industry: -

ROA

-40,92%

Sector: -26,75% Industry: -7,50%

ROE

-60,14%

Sector: -29,56% Industry: -16,97%

ROIC

Sector: -411,55% Industry: -15,18%

NET MARGIN

-100,00%

Sector: -27,20% Industry: -26,78%

GROSS MARGIN

100,00%

Sector: 43,14% Industry: 51,89%

OPERATING MARGIN

-100,00%

Sector: -23,36% Industry: -20,40%

P/EBITDA

-23,75

Sector: 0,46 Industry: 7,67

P/EBIT

-23,66

Sector: -1,06 Industry: 6,72

P/ASSET

9,97

Sector: 1,22 Industry: 1,19

BVPS

2,46

Sector: 3,68 Industry: 8,92

EPS

-1,48

Sector: -0,75 Industry: -0,02

EQUITY / ASSETS

0,68

Sector: 0,45 Industry: 0,45

CAGR REVENUES 5 YEARS

14,87%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

5,21%

Sector: - Industry: -

EYEG indicators history

DRAG THE FRAME TO SEE MORE DATA

comparator of Stocks

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	49,21	37,01	75,21%	0,77%	US$ 679,14 B	25,91%
ISRG	62,05	9,34	15,04%	0,00%	US$ 167,60 B	28,29%
TMO	28,34	3,68	12,99%	0,33%	US$ 186,20 B	15,12%
SNY	7,20	1,41	19,52%	4,76%	US$ 113,97 B	22,40%
MDT	26,78	0,00	0,00%	3,02%	US$ 119,10 B	12,81%
CVS	17,09	1,20	7,05%	3,61%	US$ 93,41 B	1,40%
GSK	12,45	4,18	33,57%	4,01%	US$ 81,40 B	15,70%
ABT	16,54	4,55	27,50%	1,75%	US$ 231,23 B	32,43%
NVS	17,42	6,01	34,49%	2,98%	US$ 252,71 B	25,52%
TMDX	34,55	11,12	32,18%	0,00%	US$ 3,54 B	17,65%
BSX	55,99	7,01	12,51%	0,00%	US$ 158,69 B	14,65%
HCA	15,83	-81,23	-513,25%	0,66%	US$ 100,56 B	8,61%
INMD	6,11	1,50	24,58%	0,00%	US$ 943,74 M	42,09%
DHR	45,57	2,74	6,02%	0,59%	US$ 143,55 B	13,04%
IDXX	49,14	35,26	71,76%	0,00%	US$ 51,44 B	25,09%
FMS	19,30	0,88	4,56%	3,18%	US$ 14,54 B	3,48%
PHG	92,36	2,20	2,38%	3,17%	US$ 26,42 B	1,45%
HUM	22,70	2,04	8,97%	1,15%	US$ 37,26 B	1,30%
RMD	27,53	6,78	24,62%	0,77%	US$ 40,45 B	27,88%

comparison of EYEG with indexes

If you had invested (change) 2 years years ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

dividend history EYEG dividend history

current DY: 0,25%

5-year average DY: 0,25%

DRAG THE FRAME TO SEE MORE DATA

type	date with	payment date	value
Dividends	02/09/2025	05/09/2025	0,14170000
Dividends	01/08/2025	06/08/2025	0,14980000
Dividends	01/07/2025	07/07/2025	0,14200000
Dividends	02/06/2025	05/06/2025	0,15100000
Dividends	01/05/2025	06/05/2025	0,15010000
Dividends	01/04/2025	04/04/2025	0,15300000
Dividends	03/03/2025	06/03/2025	0,13900000
Dividends	03/02/2025	06/02/2025	0,14100000
Dividends	30/12/2024	02/01/2025	0,47100000
Dividends	02/12/2024	05/12/2024	0,14600000
Dividends	01/11/2024	06/11/2024	0,15150000
Dividends	01/10/2024	04/10/2024	0,14750000
Dividends	03/09/2024	06/09/2024	0,14920000
Dividends	01/08/2024	06/08/2024	0,15460000
Dividends	01/07/2024	05/07/2024	0,14990000
Dividends	03/06/2024	06/06/2024	0,15390000
Dividends	02/05/2024	07/05/2024	0,14840000
Dividends	02/04/2024	05/04/2024	0,15720000
Dividends	04/03/2024	07/03/2024	0,14860000
Dividends	02/02/2024	07/02/2024	0,14760000
Dividends	29/12/2023	04/01/2024	0,09130000

ABOUT THE COMPANY EyeGate Pharmaceuticals

EyeGate Pharmaceuticals Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

27 years

Foundation: 1998

2015

Year of debut on the stock exchange - 10 years

14

Employees

The Company EyeGate Pharmaceuticals Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 254,25 Milhões, having a net worth of $ 17,35 Milhões.

With a total of 14 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 24,12 Thousand, which generated a loss in the amount of $ -10,43 Milhões.

As for its main indicators, the Company has a P/E ratio of -24,37, a P/BV ratio of 14,66 and in the last 12 months the dividend yield of EYEG was at 0,25%.

The Company is traded internationally through the ticker EYEG.

Market value

US$ 254,25 Milhões

Net worth

US$ 17,35 Milhões

US$ 17.348.046,00

Assets

US$ 25,49 Milhões

US$ 25.493.339,00

Total Number of Shares

7,06 Milhões

7.062.000

Average Daily Trading Volume

US$ 3,27 Milhões

US$ 3.273.730,00

Sector

Health

Industry

Pharmaceutical Products

EYEG

EYEG revenue and profits

EYEG results

DRAG THE FRAME TO SEE MORE DATA

EYEG cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

LBPSW - 4D pharma

US$ - -0,00% (12M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 74,67 35,74% (12M)

P/L

17,09

3,61%

ROE

7,05%

P/VP

1,20

CI - Cigna

US$ 305,87 --13,60% (12M)

P/L

13,98

1,91%

ROE

14,37%

P/VP

2,01

CNC - Centene

US$ 34,08 --54,45% (12M)

P/L

13,16

0,00%

ROE

3,96%

P/VP

0,52

HUM - Humana

US$ 278,72 --12,71% (12M)

P/L

22,70

1,15%

ROE

8,97%

P/VP

2,04

SNY - Sanofi

US$ 47,65 --12,31% (12M)

P/L

7,20

4,76%

ROE

19,52%

P/VP

1,41

HCA - HCA Healthcare

US$ 402,85 3,09% (12M)

P/L

15,83

0,66%

ROE

-513,25%

P/VP

-81,23

LLY - Eli Lilly

US$ 756,28 --17,50% (12M)

P/L

49,21

0,77%

ROE

75,21%

P/VP

37,01

LBPSW - 4D pharma

US$ - -0,00% (12 M)

P/L

0,00

0,00%

ROE

-300,00%

P/VP

0,00

CVS - CVS Health

US$ 74,67 35,74% (12 M)

P/L

17,09

3,61%

ROE

7,05%

P/VP

1,20

CI - Cigna

US$ 305,87 --13,60% (12 M)

P/L

13,98

1,91%

ROE

14,37%

P/VP

2,01

CNC - Centene

US$ 34,08 --54,45% (12 M)

P/L

13,16

0,00%

ROE

3,96%

P/VP

0,52

HUM - Humana

US$ 278,72 --12,71% (12 M)

P/L

22,70

1,15%

ROE

8,97%

P/VP

2,04

SNY - Sanofi

US$ 47,65 --12,31% (12 M)

P/L

7,20

4,76%

ROE

19,52%

P/VP

1,41

HCA - HCA Healthcare

US$ 402,85 3,09% (12 M)

P/L

15,83

0,66%

ROE

-513,25%

P/VP

-81,23

LLY - Eli Lilly

US$ 756,28 --17,50% (12 M)

P/L

49,21

0,77%

ROE

75,21%

P/VP

37,01

Common Questions

What is the price of EyeGate Pharmaceuticals (EYEG) today?

The price of EyeGate Pharmaceuticals (EYEG) today is R$ 195,95, with a variation of 4.37% compared to the last year. The price of EyeGate Pharmaceuticals (EYEG) started the year trading around R$ 188,60 and today it is at R$ 195,95. Follow the real-time price chart, the historical price of EyeGate Pharmaceuticals (EYEG), and stock data from Ibovespa and international markets.

When does EyeGate Pharmaceuticals (EYEG) pay dividends?

EyeGate Pharmaceuticals (EYEG) distributed dividends in the last year,in the months of January, February, March, April, May, June, July, August, September, October, November e December totaling R$ 9,41. The Dividend Yield for the last 12 months is 0,25%.

EyeGate Pharmaceuticals (EYEG) is it worth it?

Currently, EyeGate Pharmaceuticals (EYEG) is priced at R$ 195,95, with a P/E of -24,37%, representing a deviation of -1,12% from its historical average P/E. In the last year, the stock showed a variation of 4.37% in its price and distributed R$ 9,41 in dividends, resulting in a Dividend Yield of 0,25%. The total shareholder return was 4,37%.

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

How to buy stocks of EyeGate Pharmaceuticals (EYEG)?

Investing in stocks of EyeGate Pharmaceuticals (EYEG) can be done in two ways: by buying the stock abroad or the BDR in Brazil (if available). The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.

BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

How much do 100 stocks of EyeGate Pharmaceuticals (EYEG) yield today?

The yield of EyeGate Pharmaceuticals (EYEG) was 2,38% in the last month, 4,37% in the last year and 941,29% in the last 5 years (already considering appreciation and dividends).

In the last 12 months, the company paid a total of R$ 11,23 in dividends, um Dividend Yield de 0,25%.

If you wanted to buy 100 stocks of EyeGate Pharmaceuticals (EYEG) today, the total investment would be R$ 19.595,35, based on the current price of R$ 195,95.

If past performance were to repeat, the return on your investment would be:

In 1 year: R$ 20.451,66
In 5 years: R$ 204.044,37
In 10 years: 13.393,42

It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

EYEG

EyeGate Pharmaceuticals Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

profitability of EYEG

check out the fundamentals of EyeGate Pharmaceuticals shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, today you would have

current DY: 0,25%

5-year average DY: 0,25%

type

date with

payment date

value

ABOUT THE COMPANY EyeGate Pharmaceuticals

EyeGate Pharmaceuticals Inc.

Estados Unidos

27 years

2015

14

PROFIT X PRICE EYEG

EYEG results

EYEG cash flow

evolution of assets - EYEG

EYEG balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Common Questions

Tudo que o investidor precisa em um só lugar

Pague 2, Leve 3

Anual

Valor total R$ 238,80